Clinical Proteomic Tumour Analysis Consortium (CPTAC) data also revealed upregulation of Rad50 in ovarian, breast, colon cancers and Clear cell renal cell carcinoma (Figure S1C).26 Here, RAD50 is linked to neoplasm.